APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

EPA and DHA Omega-3 Ingredients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EPA and DHA Omega-3 Ingredients Market Outlook and Growth Opportunities 2026

Report ID 174476660413 August 2026197 pages

Choose your research edition.

Industry ResearchEPA and DHA Omega-3 Ingredients Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA and DHA Omega-3 Ingredients Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal EPA and DHA Omega-3 Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA and DHA Omega-3 Ingredients Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA and DHA Omega-3 Ingredients Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global EPA and DHA Omega-3 Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA and DHA Omega-3 Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EPA and DHA Omega-3 Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EPA and DHA Omega-3 Ingredients market include Alaska Omega, Omega Protein Corporation, Cargill, BASF SE, The Archer Daniels Midland Company, Wiley Companies, Novotech Nutraceuticals, Koninklijke DSM and Croda International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA and DHA Omega-3 Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA and DHA Omega-3 Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA and DHA Omega-3 Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA and DHA Omega-3 Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA and DHA Omega-3 Ingredients Segment by Company

Alaska Omega

Omega Protein Corporation

Cargill

BASF SE

The Archer Daniels Midland Company

Wiley Companies

Novotech Nutraceuticals

Koninklijke DSM

Croda International

Epax Norway AS

Golden Omega SA

KD Pharma Group

Novasep Holding SAS

Lyxia Corporation

EPA and DHA Omega-3 Ingredients Segment by Type

Fish Oil

Algae Oil

Others

EPA and DHA Omega-3 Ingredients Segment by Application

Food and Beverages

Dietary Supplements and Nutraceutical

Infant Formulas

Pharmaceutical and Clinical Nutrition

Animal Feed

Others

EPA and DHA Omega-3 Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global EPA and DHA Omega-3 Ingredients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EPA and DHA Omega-3 Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EPA and DHA Omega-3 Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze EPA and DHA Omega-3 Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA Omega-3 Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA Omega-3 Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA Omega-3 Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA and DHA Omega-3 Ingredients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EPA and DHA Omega-3 Ingredients industry.

Chapter 3: Detailed analysis of EPA and DHA Omega-3 Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EPA and DHA Omega-3 Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EPA and DHA Omega-3 Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EPA and DHA Omega-3 Ingredients Industry Trends Table 2. EPA and DHA Omega-3 Ingredients Industry Drivers Table 3. EPA and DHA Omega-3 Ingredients Industry Opportunities and Challenges Table 4. EPA and DHA Omega-3 Ingredients Industry Restraints Table 5. Global EPA and DHA Omega-3 Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EPA and DHA Omega-3 Ingredients Revenue Share by Company (2021-2026) Table 7. Global EPA and DHA Omega-3 Ingredients Sales Volume by Company (k units) & (2021-2026) Table 8. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Company (2021-2026) Table 9. Global EPA and DHA Omega-3 Ingredients Average Price (USD/unit) of Company (2021-2026) Table 10. Global EPA and DHA Omega-3 Ingredients Company Ranking, (2024-2026) & (USD Million) Table 11. Global EPA and DHA Omega-3 Ingredients Key Company Manufacturing Base & Headquarters Table 12. Global EPA and DHA Omega-3 Ingredients Company, Product Type & Application Table 13. Global EPA and DHA Omega-3 Ingredients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA and DHA Omega-3 Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fish Oil Table 18. Significant Companies of Algae Oil Table 19. Significant Companies of Others Table 20. Global EPA and DHA Omega-3 Ingredients Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global EPA and DHA Omega-3 Ingredients Sales Volume by Type (2021-2026) & (k units) Table 22. Global EPA and DHA Omega-3 Ingredients Sales Volume by Type (2027-2032) & (k units) Table 23. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Type (2021-2026) Table 24. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Type (2027-2032) Table 25. Global EPA and DHA Omega-3 Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global EPA and DHA Omega-3 Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global EPA and DHA Omega-3 Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Type (2021-2026) Table 29. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food and Beverages Table 31. Significant Companies of Dietary Supplements and Nutraceutical Table 32. Significant Companies of Infant Formulas Table 33. Significant Companies of Pharmaceutical and Clinical Nutrition Table 34. Significant Companies of Animal Feed Table 35. Significant Companies of Others Table 36. Global EPA and DHA Omega-3 Ingredients Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global EPA and DHA Omega-3 Ingredients Sales Volume by Application (2021-2026) & (k units) Table 38. Global EPA and DHA Omega-3 Ingredients Sales Volume by Application (2027-2032) & (k units) Table 39. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Application (2021-2026) Table 40. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Application (2027-2032) Table 41. Global EPA and DHA Omega-3 Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global EPA and DHA Omega-3 Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global EPA and DHA Omega-3 Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Application (2021-2026) Table 45. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Application (2027-2032) Table 46. Global EPA and DHA Omega-3 Ingredients Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global EPA and DHA Omega-3 Ingredients Sales by Region (2021-2026) & (k units) Table 48. Global EPA and DHA Omega-3 Ingredients Sales Market Share by Region (2021-2026) Table 49. Global EPA and DHA Omega-3 Ingredients Sales by Region (2027-2032) & (k units) Table 50. Global EPA and DHA Omega-3 Ingredients Sales Market Share by Region (2027-2032) Table 51. Global EPA and DHA Omega-3 Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global EPA and DHA Omega-3 Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Region (2021-2026) Table 54. Global EPA and DHA Omega-3 Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Region (2027-2032) Table 56. Global EPA and DHA Omega-3 Ingredients Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global EPA and DHA Omega-3 Ingredients Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global EPA and DHA Omega-3 Ingredients Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global EPA and DHA Omega-3 Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global EPA and DHA Omega-3 Ingredients Sales by Country (2021-2026) & (k units) Table 61. Global EPA and DHA Omega-3 Ingredients Sales Market Share by Country (2021-2026) Table 62. Global EPA and DHA Omega-3 Ingredients Sales by Country (2027-2032) & (k units) Table 63. Global EPA and DHA Omega-3 Ingredients Sales Market Share by Country (2027-2032) Table 64. Global EPA and DHA Omega-3 Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global EPA and DHA Omega-3 Ingredients Sales Value Market Share by Country (2021-2026) Table 66. Global EPA and DHA Omega-3 Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global EPA and DHA Omega-3 Ingredients Sales Value Market Share by Country (2027-2032) Table 68. Alaska Omega Company Information Table 69. Alaska Omega Business Overview Table 70. Alaska Omega EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Alaska Omega EPA and DHA Omega-3 Ingredients Product Portfolio Table 72. Alaska Omega Recent Development Table 73. Omega Protein Corporation Company Information Table 74. Omega Protein Corporation Business Overview Table 75. Omega Protein Corporation EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Omega Protein Corporation EPA and DHA Omega-3 Ingredients Product Portfolio Table 77. Omega Protein Corporation Recent Development Table 78. Cargill Company Information Table 79. Cargill Business Overview Table 80. Cargill EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Cargill EPA and DHA Omega-3 Ingredients Product Portfolio Table 82. Cargill Recent Development Table 83. BASF SE Company Information Table 84. BASF SE Business Overview Table 85. BASF SE EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. BASF SE EPA and DHA Omega-3 Ingredients Product Portfolio Table 87. BASF SE Recent Development Table 88. The Archer Daniels Midland Company Company Information Table 89. The Archer Daniels Midland Company Business Overview Table 90. The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Product Portfolio Table 92. The Archer Daniels Midland Company Recent Development Table 93. Wiley Companies Company Information Table 94. Wiley Companies Business Overview Table 95. Wiley Companies EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Wiley Companies EPA and DHA Omega-3 Ingredients Product Portfolio Table 97. Wiley Companies Recent Development Table 98. Novotech Nutraceuticals Company Information Table 99. Novotech Nutraceuticals Business Overview Table 100. Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Product Portfolio Table 102. Novotech Nutraceuticals Recent Development Table 103. Koninklijke DSM Company Information Table 104. Koninklijke DSM Business Overview Table 105. Koninklijke DSM EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Koninklijke DSM EPA and DHA Omega-3 Ingredients Product Portfolio Table 107. Koninklijke DSM Recent Development Table 108. Croda International Company Information Table 109. Croda International Business Overview Table 110. Croda International EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Croda International EPA and DHA Omega-3 Ingredients Product Portfolio Table 112. Croda International Recent Development Table 113. Epax Norway AS Company Information Table 114. Epax Norway AS Business Overview Table 115. Epax Norway AS EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Epax Norway AS EPA and DHA Omega-3 Ingredients Product Portfolio Table 117. Epax Norway AS Recent Development Table 118. Golden Omega SA Company Information Table 119. Golden Omega SA Business Overview Table 120. Golden Omega SA EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Golden Omega SA EPA and DHA Omega-3 Ingredients Product Portfolio Table 122. Golden Omega SA Recent Development Table 123. KD Pharma Group Company Information Table 124. KD Pharma Group Business Overview Table 125. KD Pharma Group EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. KD Pharma Group EPA and DHA Omega-3 Ingredients Product Portfolio Table 127. KD Pharma Group Recent Development Table 128. Novasep Holding SAS Company Information Table 129. Novasep Holding SAS Business Overview Table 130. Novasep Holding SAS EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Novasep Holding SAS EPA and DHA Omega-3 Ingredients Product Portfolio Table 132. Novasep Holding SAS Recent Development Table 133. Lyxia Corporation Company Information Table 134. Lyxia Corporation Business Overview Table 135. Lyxia Corporation EPA and DHA Omega-3 Ingredients Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Lyxia Corporation EPA and DHA Omega-3 Ingredients Product Portfolio Table 137. Lyxia Corporation Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. EPA and DHA Omega-3 Ingredients Distributors List Table 141. EPA and DHA Omega-3 Ingredients Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. EPA and DHA Omega-3 Ingredients Product Image Figure 2. Global EPA and DHA Omega-3 Ingredients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 4. Global EPA and DHA Omega-3 Ingredients Sales (2021-2032) & (k units) Figure 5. Global EPA and DHA Omega-3 Ingredients Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global EPA and DHA Omega-3 Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fish Oil Image Figure 10. Algae Oil Image Figure 11. Others Image Figure 12. Global EPA and DHA Omega-3 Ingredients Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global EPA and DHA Omega-3 Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Type (2021-2032) Figure 15. Global EPA and DHA Omega-3 Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global EPA and DHA Omega-3 Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Type (2021-2032) Figure 18. Food and Beverages Image Figure 19. Dietary Supplements and Nutraceutical Image Figure 20. Infant Formulas Image Figure 21. Pharmaceutical and Clinical Nutrition Image Figure 22. Animal Feed Image Figure 23. Others Image Figure 24. Global EPA and DHA Omega-3 Ingredients Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global EPA and DHA Omega-3 Ingredients Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Application (2021-2032) Figure 27. Global EPA and DHA Omega-3 Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global EPA and DHA Omega-3 Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Application (2021-2032) Figure 30. Global EPA and DHA Omega-3 Ingredients Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global EPA and DHA Omega-3 Ingredients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global EPA and DHA Omega-3 Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global EPA and DHA Omega-3 Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 35. North America EPA and DHA Omega-3 Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 37. Europe EPA and DHA Omega-3 Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific EPA and DHA Omega-3 Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 41. South America EPA and DHA Omega-3 Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa EPA and DHA Omega-3 Ingredients Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa EPA and DHA Omega-3 Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. EPA and DHA Omega-3 Ingredients Value Chain Figure 129. Manufacturing Cost Structure Figure 130. EPA and DHA Omega-3 Ingredients Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Fish Oil
  • Algae Oil
  • Others
Applications
  • Food and Beverages
  • Dietary Supplements and Nutraceutical
  • Infant Formulas
  • Pharmaceutical and Clinical Nutrition
  • Animal Feed
  • Others
Companies covered
  • Alaska Omega
  • Omega Protein Corporation
  • Cargill
  • BASF SE
  • The Archer Daniels Midland Company
  • Wiley Companies
  • Novotech Nutraceuticals
  • Koninklijke DSM
  • Croda International
  • Epax Norway AS
  • Golden Omega SA
  • KD Pharma Group
  • Novasep Holding SAS
  • Lyxia Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  4. 1.2.2 Global EPA and DHA Omega-3 Ingredients Sales Volume (2021-2032)
  5. 1.2.3 Global EPA and DHA Omega-3 Ingredients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EPA and DHA Omega-3 Ingredients Market Dynamics
  1. 2.1 EPA and DHA Omega-3 Ingredients Industry Trends
  2. 2.2 EPA and DHA Omega-3 Ingredients Industry Drivers
  3. 2.3 EPA and DHA Omega-3 Ingredients Industry Opportunities and Challenges
  4. 2.4 EPA and DHA Omega-3 Ingredients Industry Restraints
3 EPA and DHA Omega-3 Ingredients Market by Company
  1. 3.1 Global EPA and DHA Omega-3 Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global EPA and DHA Omega-3 Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global EPA and DHA Omega-3 Ingredients Sales Volume by Company (2021-2026)
  4. 3.4 Global EPA and DHA Omega-3 Ingredients Average Price by Company (2021-2026)
  5. 3.5 Global EPA and DHA Omega-3 Ingredients Company Ranking (2024-2026)
  6. 3.6 Global EPA and DHA Omega-3 Ingredients Company Manufacturing Base and Headquarters
  7. 3.7 Global EPA and DHA Omega-3 Ingredients Company Product Type and Application
  8. 3.8 Global EPA and DHA Omega-3 Ingredients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EPA and DHA Omega-3 Ingredients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EPA and DHA Omega-3 Ingredients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EPA and DHA Omega-3 Ingredients Market by Type
  1. 4.1 EPA and DHA Omega-3 Ingredients Type Introduction
  2. 4.1.1 Fish Oil
  3. 4.1.2 Algae Oil
  4. 4.1.3 Others
  5. 4.2 Global EPA and DHA Omega-3 Ingredients Sales Volume by Type
  6. 4.2.1 Global EPA and DHA Omega-3 Ingredients Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global EPA and DHA Omega-3 Ingredients Sales Volume by Type (2021-2032)
  8. 4.2.3 Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Type (2021-2032)
  9. 4.3 Global EPA and DHA Omega-3 Ingredients Sales Value by Type
  10. 4.3.1 Global EPA and DHA Omega-3 Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global EPA and DHA Omega-3 Ingredients Sales Value by Type (2021-2032)
  12. 4.3.3 Global EPA and DHA Omega-3 Ingredients Sales Value Share by Type (2021-2032)
5 EPA and DHA Omega-3 Ingredients Market by Application
  1. 5.1 EPA and DHA Omega-3 Ingredients Application Introduction
  2. 5.1.1 Food and Beverages
  3. 5.1.2 Dietary Supplements and Nutraceutical
  4. 5.1.3 Infant Formulas
  5. 5.1.4 Pharmaceutical and Clinical Nutrition
  6. 5.1.5 Animal Feed
  7. 5.1.6 Others
  8. 5.2 Global EPA and DHA Omega-3 Ingredients Sales Volume by Application
  9. 5.2.1 Global EPA and DHA Omega-3 Ingredients Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global EPA and DHA Omega-3 Ingredients Sales Volume by Application (2021-2032)
  11. 5.2.3 Global EPA and DHA Omega-3 Ingredients Sales Volume Share by Application (2021-2032)
  12. 5.3 Global EPA and DHA Omega-3 Ingredients Sales Value by Application
  13. 5.3.1 Global EPA and DHA Omega-3 Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global EPA and DHA Omega-3 Ingredients Sales Value by Application (2021-2032)
  15. 5.3.3 Global EPA and DHA Omega-3 Ingredients Sales Value Share by Application (2021-2032)
6 EPA and DHA Omega-3 Ingredients Regional Sales and Value Analysis
  1. 6.1 Global EPA and DHA Omega-3 Ingredients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA and DHA Omega-3 Ingredients Sales by Region (2021-2032)
  3. 6.2.1 Global EPA and DHA Omega-3 Ingredients Sales by Region: 2021-2026
  4. 6.2.2 Global EPA and DHA Omega-3 Ingredients Sales by Region (2027-2032)
  5. 6.3 Global EPA and DHA Omega-3 Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EPA and DHA Omega-3 Ingredients Sales Value by Region (2021-2032)
  7. 6.4.1 Global EPA and DHA Omega-3 Ingredients Sales Value by Region: 2021-2026
  8. 6.4.2 Global EPA and DHA Omega-3 Ingredients Sales Value by Region (2027-2032)
  9. 6.5 Global EPA and DHA Omega-3 Ingredients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  12. 6.6.2 North America EPA and DHA Omega-3 Ingredients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  15. 6.7.2 Europe EPA and DHA Omega-3 Ingredients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EPA and DHA Omega-3 Ingredients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  21. 6.9.2 South America EPA and DHA Omega-3 Ingredients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EPA and DHA Omega-3 Ingredients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EPA and DHA Omega-3 Ingredients Sales Value Share by Country, 2025 VS 2032
7 EPA and DHA Omega-3 Ingredients Country-level Sales and Value Analysis
  1. 7.1 Global EPA and DHA Omega-3 Ingredients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EPA and DHA Omega-3 Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EPA and DHA Omega-3 Ingredients Sales by Country (2021-2032)
  4. 7.3.1 Global EPA and DHA Omega-3 Ingredients Sales by Country (2021-2026)
  5. 7.3.2 Global EPA and DHA Omega-3 Ingredients Sales by Country (2027-2032)
  6. 7.4 Global EPA and DHA Omega-3 Ingredients Sales Value by Country (2021-2032)
  7. 7.4.1 Global EPA and DHA Omega-3 Ingredients Sales Value by Country (2021-2026)
  8. 7.4.2 Global EPA and DHA Omega-3 Ingredients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EPA and DHA Omega-3 Ingredients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EPA and DHA Omega-3 Ingredients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EPA and DHA Omega-3 Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alaska Omega
  2. 8.1.1 Alaska Omega Company Information
  3. 8.1.2 Alaska Omega Business Overview
  4. 8.1.3 Alaska Omega EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alaska Omega EPA and DHA Omega-3 Ingredients Product Portfolio
  6. 8.1.5 Alaska Omega Recent Developments
  7. 8.2 Omega Protein Corporation
  8. 8.2.1 Omega Protein Corporation Company Information
  9. 8.2.2 Omega Protein Corporation Business Overview
  10. 8.2.3 Omega Protein Corporation EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Omega Protein Corporation EPA and DHA Omega-3 Ingredients Product Portfolio
  12. 8.2.5 Omega Protein Corporation Recent Developments
  13. 8.3 Cargill
  14. 8.3.1 Cargill Company Information
  15. 8.3.2 Cargill Business Overview
  16. 8.3.3 Cargill EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cargill EPA and DHA Omega-3 Ingredients Product Portfolio
  18. 8.3.5 Cargill Recent Developments
  19. 8.4 BASF SE
  20. 8.4.1 BASF SE Company Information
  21. 8.4.2 BASF SE Business Overview
  22. 8.4.3 BASF SE EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BASF SE EPA and DHA Omega-3 Ingredients Product Portfolio
  24. 8.4.5 BASF SE Recent Developments
  25. 8.5 The Archer Daniels Midland Company
  26. 8.5.1 The Archer Daniels Midland Company Company Information
  27. 8.5.2 The Archer Daniels Midland Company Business Overview
  28. 8.5.3 The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 The Archer Daniels Midland Company EPA and DHA Omega-3 Ingredients Product Portfolio
  30. 8.5.5 The Archer Daniels Midland Company Recent Developments
  31. 8.6 Wiley Companies
  32. 8.6.1 Wiley Companies Company Information
  33. 8.6.2 Wiley Companies Business Overview
  34. 8.6.3 Wiley Companies EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Wiley Companies EPA and DHA Omega-3 Ingredients Product Portfolio
  36. 8.6.5 Wiley Companies Recent Developments
  37. 8.7 Novotech Nutraceuticals
  38. 8.7.1 Novotech Nutraceuticals Company Information
  39. 8.7.2 Novotech Nutraceuticals Business Overview
  40. 8.7.3 Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novotech Nutraceuticals EPA and DHA Omega-3 Ingredients Product Portfolio
  42. 8.7.5 Novotech Nutraceuticals Recent Developments
  43. 8.8 Koninklijke DSM
  44. 8.8.1 Koninklijke DSM Company Information
  45. 8.8.2 Koninklijke DSM Business Overview
  46. 8.8.3 Koninklijke DSM EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Koninklijke DSM EPA and DHA Omega-3 Ingredients Product Portfolio
  48. 8.8.5 Koninklijke DSM Recent Developments
  49. 8.9 Croda International
  50. 8.9.1 Croda International Company Information
  51. 8.9.2 Croda International Business Overview
  52. 8.9.3 Croda International EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Croda International EPA and DHA Omega-3 Ingredients Product Portfolio
  54. 8.9.5 Croda International Recent Developments
  55. 8.10 Epax Norway AS
  56. 8.10.1 Epax Norway AS Company Information
  57. 8.10.2 Epax Norway AS Business Overview
  58. 8.10.3 Epax Norway AS EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Epax Norway AS EPA and DHA Omega-3 Ingredients Product Portfolio
  60. 8.10.5 Epax Norway AS Recent Developments
  61. 8.11 Golden Omega SA
  62. 8.11.1 Golden Omega SA Company Information
  63. 8.11.2 Golden Omega SA Business Overview
  64. 8.11.3 Golden Omega SA EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Golden Omega SA EPA and DHA Omega-3 Ingredients Product Portfolio
  66. 8.11.5 Golden Omega SA Recent Developments
  67. 8.12 KD Pharma Group
  68. 8.12.1 KD Pharma Group Company Information
  69. 8.12.2 KD Pharma Group Business Overview
  70. 8.12.3 KD Pharma Group EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 KD Pharma Group EPA and DHA Omega-3 Ingredients Product Portfolio
  72. 8.12.5 KD Pharma Group Recent Developments
  73. 8.13 Novasep Holding SAS
  74. 8.13.1 Novasep Holding SAS Company Information
  75. 8.13.2 Novasep Holding SAS Business Overview
  76. 8.13.3 Novasep Holding SAS EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Novasep Holding SAS EPA and DHA Omega-3 Ingredients Product Portfolio
  78. 8.13.5 Novasep Holding SAS Recent Developments
  79. 8.14 Lyxia Corporation
  80. 8.14.1 Lyxia Corporation Company Information
  81. 8.14.2 Lyxia Corporation Business Overview
  82. 8.14.3 Lyxia Corporation EPA and DHA Omega-3 Ingredients Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Lyxia Corporation EPA and DHA Omega-3 Ingredients Product Portfolio
  84. 8.14.5 Lyxia Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA and DHA Omega-3 Ingredients Value Chain Analysis
  2. 9.1.1 EPA and DHA Omega-3 Ingredients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA and DHA Omega-3 Ingredients Sales Mode & Process
  6. 9.2 EPA and DHA Omega-3 Ingredients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA and DHA Omega-3 Ingredients Distributors
  9. 9.2.3 EPA and DHA Omega-3 Ingredients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst